Pharmacist-Led Medication Simplification in Geriatric Care

Abstract

Pharmacist-led medication simplification is an evidence-based strategy to optimize pharmacotherapy in geriatric patients, who are particularly vulnerable to polypharmacy and its associated risks. This review synthesizes current research, mechanisms, clinical guidelines, and practical implications of pharmacist-driven interventions aimed at medication simplification, with a focus on improving patient safety, adherence, and outcomes in the elderly. The article discusses disease burden, pathophysiology, risk factors, diagnosis, management strategies, recent advances, and expert guideline recommendations, providing a comprehensive overview for clinicians dedicated to elderly care.

Introduction

The global rise in the aging population has resulted in a concurrent increase in multimorbidity and polypharmacy among older adults. Polypharmacy, commonly defined as the use of five or more medications, is prevalent in geriatric care and is associated with heightened risks of adverse drug events, hospitalizations, and mortality. Medication simplification, especially when led by clinical pharmacists, has emerged as a strategic approach to mitigate these risks by streamlining complex regimens, prioritizing essential therapies, and discontinuing unnecessary or redundant medications. Pharmacists, with their expertise in pharmacokinetics, pharmacodynamics, and drug interactions, are uniquely positioned to lead these interventions in collaboration with multidisciplinary healthcare teams.

Epidemiology / Disease Burden

Globally, up to 50% of older adults are exposed to polypharmacy, with a significant proportion facing medication-related problems such as non-adherence, adverse drug reactions, and hospital readmissions. The prevalence of polypharmacy is highest in individuals over 75 years and those residing in long-term care facilities. Studies estimate that medication errors contribute to approximately 10% of hospitalizations in geriatric populations, underscoring the need for targeted interventions. Furthermore, the World Health Organization highlights medication safety in the elderly as a public health priority due to the cumulative impact of chronic diseases and functional decline.

Pathophysiology

The pathophysiology underlying the risks of polypharmacy in geriatrics is multifactorial. Age-related physiological changes, such as reduced renal and hepatic function, altered body composition, and changes in receptor sensitivity, increase susceptibility to drug toxicity and interactions. Cognitive impairment, frailty, and sensory deficits further complicate medication management. These factors collectively heighten the risk of adverse drug events, therapeutic duplications, and decreased efficacy, emphasizing the importance of mechanism-based medication simplification tailored to the aging physiology.

Risk Factors

Several risk factors predispose elderly patients to polypharmacy and complex medication regimens. These include multiple chronic conditions (e.g., diabetes, hypertension, heart failure), frequent hospitalizations, transitions of care, fragmented healthcare delivery, and lack of comprehensive medication reviews. Cognitive decline, limited health literacy, and social isolation are additional contributors. Recognizing these risk factors enables healthcare professionals to identify high-risk individuals who would benefit most from pharmacist-led medication simplification.

Clinical Features

Clinically, patients experiencing polypharmacy may present with atypical symptoms such as falls, confusion, delirium, decreased functional status, and unexplained hospital admissions. These presentations are often mistakenly attributed to aging rather than medication-related harm. Other features include medication non-adherence, frequent dosing errors, and increased pill burden, all of which impair quality of life and pose significant barriers to optimal care.

Diagnosis

Diagnosis of problematic polypharmacy requires a systematic medication review, often led by pharmacists, utilizing tools such as the Medication Appropriateness Index, STOPP/START criteria, and Beers Criteria. Comprehensive assessment includes evaluating drug indications, potential interactions, duplications, dosing appropriateness, and patient-specific factors such as renal function. Collaboration with patients and caregivers is crucial to identify discrepancies, adverse effects, and adherence challenges, which inform the design of simplified regimens.

Treatment & Management

Pharmacist-led interventions focus on deprescribing unnecessary medications, consolidating dosing schedules, and selecting formulations that enhance adherence. Strategies include therapeutic substitution, dose optimization, and synchronization of medication administration times. Effective communication and shared decision-making with patients, families, and the healthcare team are key. Pharmacists also provide education and support to empower patients in self-management, thereby improving medication adherence and clinical outcomes.

Recent Advances / Emerging Therapies

Recent studies highlight the efficacy of structured pharmacist-led medication simplification programs, such as the SIMPLER (Simplification of Medications Prescribed to Long-tErm caRe residents) trial, which demonstrated improved medication appropriateness and reduced regimen complexity without compromising disease control. Digital health tools, including electronic medication reconciliation platforms and adherence-monitoring devices, are increasingly integrated into practice. Pharmacogenomics and individualized medicine are also emerging, offering tailored approaches to medication selection and dosing in geriatric care.

Guideline Recommendations

Clinical guidelines from leading organizations, including the American Geriatrics Society and the Society of Hospital Pharmacists of Australia, advocate for routine medication reviews and simplification in elderly patients, particularly at care transitions. Recommendations emphasize multidisciplinary collaboration, patient-centered deprescribing, and regular reassessment of medication regimens. Guidelines also highlight the need for ongoing education and training for pharmacists and other healthcare professionals involved in geriatric care.

Conclusion

Pharmacist-led medication simplification represents a critical strategy in the optimization of pharmacotherapy for geriatric patients. By addressing polypharmacy through evidence-based interventions, pharmacists contribute to improved safety, adherence, and quality of life in older adults. Ongoing research, integration of technology, and adherence to clinical guidelines are essential to maximize the benefits of these interventions. Multidisciplinary collaboration and patient engagement remain central to the successful implementation of medication simplification in geriatric care.